SteelPeak Wealth LLC lowered its position in shares of Herbalife Ltd. (NYSE:HLF - Free Report) by 10.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 450,000 shares of the company's stock after selling 50,000 shares during the period. SteelPeak Wealth LLC owned 0.45% of Herbalife worth $3,010,000 as of its most recent filing with the SEC.
A number of other large investors have also modified their holdings of HLF. Iridian Asset Management LLC CT boosted its position in Herbalife by 43.7% during the 3rd quarter. Iridian Asset Management LLC CT now owns 2,228,193 shares of the company's stock worth $16,021,000 after acquiring an additional 677,739 shares during the period. Perpetual Ltd grew its position in Herbalife by 107.1% in the 4th quarter. Perpetual Ltd now owns 966,063 shares of the company's stock valued at $6,463,000 after buying an additional 499,572 shares in the last quarter. Hotchkis & Wiley Capital Management LLC grew its position in Herbalife by 20.2% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,287,600 shares of the company's stock valued at $16,448,000 after buying an additional 384,100 shares in the last quarter. Jacobs Levy Equity Management Inc. raised its position in shares of Herbalife by 15.5% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 1,539,148 shares of the company's stock worth $11,066,000 after buying an additional 206,530 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Herbalife by 6.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,479,957 shares of the company's stock worth $17,831,000 after acquiring an additional 160,792 shares during the period.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the company. StockNews.com raised Herbalife from a "hold" rating to a "buy" rating in a report on Monday, November 4th. Citigroup cut their price objective on Herbalife from $16.00 to $13.00 and set a "buy" rating for the company in a report on Friday, October 25th. Mizuho lifted their target price on Herbalife from $8.00 to $9.00 and gave the stock a "neutral" rating in a report on Friday, November 1st. DA Davidson dropped their price target on shares of Herbalife from $13.00 to $7.50 and set a "neutral" rating on the stock in a research report on Thursday, October 31st. Finally, B. Riley cut their target price on shares of Herbalife from $17.00 to $12.00 and set a "buy" rating for the company in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Herbalife has a consensus rating of "Hold" and a consensus target price of $9.90.
Read Our Latest Report on Herbalife
Herbalife Price Performance
NYSE HLF traded down $0.26 on Friday, hitting $5.45. 3,176,356 shares of the company were exchanged, compared to its average volume of 1,652,783. Herbalife Ltd. has a twelve month low of $5.41 and a twelve month high of $12.81. The company's 50 day moving average price is $6.93 and its 200-day moving average price is $7.81. The firm has a market capitalization of $548.80 million, a P/E ratio of 6.41, a price-to-earnings-growth ratio of 0.19 and a beta of 1.18.
Herbalife (NYSE:HLF - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.19 by $0.38. Herbalife had a net margin of 1.73% and a negative return on equity of 18.66%. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.23 billion. As a group, equities analysts expect that Herbalife Ltd. will post 1.51 EPS for the current year.
Herbalife Profile
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
See Also
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.